LIN28: A cancer stem cell promoter for immunotherapy in head and neck squamous cell carcinoma. [electronic resource]
- Oral oncology 11 2019
- 92-95 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1879-0593
10.1016/j.oraloncology.2019.09.024 doi
Biomarkers, Tumor Cell Self Renewal Cellular Reprogramming--genetics Disease Susceptibility--immunology Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Humans Immunotherapy--methods MicroRNAs--genetics Neoplastic Stem Cells--immunology RNA Interference RNA-Binding Proteins--genetics Squamous Cell Carcinoma of Head and Neck--etiology